This fact sheet emphasizes the critical role of a structured data aggregation strategy in specialty markets. IQVIA’s consulting team helps companies evaluate data partners, build aggregation roadmaps, and identify reporting requirements that align with launch objectives and field needs. Benefits include improved patient journey insights, better provider targeting, streamlined contracting, and compliance monitoring. The strategy addresses redundancies and integrates tokenization for patient-level analytics. With proven expertise, IQVIA enables biopharma to optimize specialty data use, strengthen operations, and support commercial success, especially for emerging companies launching their first specialty product.

Join for free to read